Fuso Pharmaceutical Industries,Ltd.

4538

JP3823600006

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 11:30:00 10/05/2024 am IST			5-day change	1st Jan Change
2,245 ^JPY	+1.45%		+1.45%	+18.72%

2023	Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 5, 2023.	CI
2023	Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 5, 2023, has closed with	CI

Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.

August 29, 2016

The Board of Directors of Fuso Pharmaceutical Industries,Ltd. has authorized a buyback plan on August 29, 2016.

Latest news about Fuso Pharmaceutical Industries,Ltd.

Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 5, 2023.	06/23/06	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 5, 2023, has closed with	06/23/06	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 340,000 shares, representing 3.88% for ¥735 million.	05/23/05	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	05/23/05	CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) dropped from S&P Global BMI Index	19/22/19	CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) added to S&P Global BMI Index	20/21/20	CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) dropped from S&P Global BMI Index	18/17/18	CI
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 4, 2017.	05/17/05	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 4, 2017 has expired with 154,100 shares, representing 1.72% for ¥421.62 million.	05/17/05	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 200,000 shares, representing 2.24% for ¥547.2 million.	04/17/04	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	04/17/04	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	24/16/24	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 866 shares, for ¥2.3 million.	24/16/24	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on October 24, 2016 has expired.	24/16/24	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on August 29, 2016 has expired with 1,050,000 shares for ¥271.95 million.	30/16/30	CI
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on August 29, 2016.	30/16/30	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	29/16/29	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 1,300,000 shares, representing 1.44% for ¥336.7 million.	29/16/29	CI
JA Mitsui Leasing, Ltd. cancelled the acquisition of Kyobashi Parking Lot of Fuso Pharmaceutical Industries,Ltd..	21/13/21	CI
JA Mitsui Leasing, Ltd. entered into an agreement to acquire Kyobashi Parking Lot of Fuso Pharmaceutical Industries,Ltd. for ¥4 billion.	21/12/21	CI

Chart Fuso Pharmaceutical Industries,Ltd.

Duration

Period

Chart Fuso Pharmaceutical Industries,Ltd.

More charts

Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
FUSO PHARMACEUTICAL INDUSTRIES,LTD.	+18.72%	122M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals